FORMULATION PHARMACEUTIQUE PARENTERALE EN SUSPENSION, A LIBERATION SOUTENUE, A DOSAGE FAIBLE ET ULTRA-FAIBLE, UTILISEE DANS L'HORMONOTHERAPIE DU SYNDROME MENOPAUSIQUE

• 收藏
• 分享

专利权人:

S.A. DE C.V.;TECHSPHERE

发明人:

ANGELES URIBE, JUAN,SAVOIR VILBOEUF, JOHN CLAUDE

申请号：

CA2781999

公开号：

CA2781999C

申请日:

2010.12.14

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

Parenteral pharmaceutical formulation or composition, in suspension, having sustained release, containing suspended particles of estradiol and progesterone for hormonal replacement in female mammals in low and ultralow dosage； the formulation consists of an injectable suspension comprising particles of estradiol, particles of progesterone, a surfactant agent, an isosmotic agent, a thickening agent, and one or more preservation agents, wherein the estradiol is in particles having a size between 1 and 100 microns and the progesterone is in particles having a size between 1 and 100 microns, for application thereof in parenteral, intramuscular, subcutaneous or intradermal pharmaceutical form.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/